Literature DB >> 3103609

Effect of fructose 1-phosphate on the activation of liver glycogen synthase.

M Bollen, L Mvumbi, W Stalmans, B Tóth, I Farkas, G Bot, P Gergely.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3103609      PMCID： PMC1147414          DOI： 10.1042/bj2400309

Source DB:  PubMed          Journal:  Biochem J        ISSN： 0264-6021            Impact factor:   3.857


× No keyword cloud information.
  7 in total

1.  The inactivation of glycogen phosphorylase is not a prerequisite for the activation of liver glycogen synthase.

Authors:  C J Ciudad; J Massagué; J J Guinovart
Journal:  FEBS Lett       Date:  1979-03-15       Impact factor: 4.124

2.  Cyclic AMP-mediated activation of hepatic glycogenolysis by fructose.

Authors:  T B Miller
Journal:  Biochim Biophys Acta       Date:  1978-04-19

Review 3.  The role of the liver in the homeostasis of blood glucose.

Authors:  W Stalmans
Journal:  Curr Top Cell Regul       Date:  1976

4.  Dicyclohexylamine is not an inhibitor of spermidine synthase.

Authors:  K W Batchelor; R A Smith; N S Watson
Journal:  Biochem J       Date:  1986-01-01       Impact factor: 3.857

5.  On the mechanism of hepatic glycogenolysis induced by anoxia or cyanide.

Authors:  M Bollen; D de Ruysscher; W Stalmans
Journal:  Biochem Biophys Res Commun       Date:  1983-09-30       Impact factor: 3.575

6.  Mechanism of activation of glycogen phosphorylase by fructose in the liver. Stimulation of phosphorylase kinase related to the consumption of adenosine triphosphate.

Authors:  G Van de Werve; H G Hers
Journal:  Biochem J       Date:  1979-01-15       Impact factor: 3.857

7.  Effect of fructose 1-phosphate on the activation of liver glycogen synthase.

Authors:  P Gergely; B Tóth; I Farkas; G Bot
Journal:  Biochem J       Date:  1985-11-15       Impact factor: 3.857
  7 in total
  1 in total

1.  Ketohexokinase C blockade ameliorates fructose-induced metabolic dysfunction in fructose-sensitive mice.

Authors:  Miguel A Lanaspa; Ana Andres-Hernando; David J Orlicky; Christina Cicerchi; Cholsoon Jang; Nanxing Li; Tamara Milagres; Masanari Kuwabara; Michael F Wempe; Joshua D Rabinowitz; Richard J Johnson; Dean R Tolan
Journal:  J Clin Invest       Date:  2018-04-23       Impact factor: 14.808
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.